Published in Biol Psychiatry on January 15, 2011
Omega-3 fatty acid deficiency disrupts endocytosis, neuritogenesis, and mitochondrial protein pathways in the mouse hippocampus. Front Genet (2013) 1.43
Schizophrenia interactome with 504 novel protein-protein interactions. NPJ Schizophr (2016) 1.40
Recent advances in quantitative neuroproteomics. Methods (2013) 1.23
14-3-3 proteins in neurological disorders. Int J Biochem Mol Biol (2012) 1.05
Extracellular matrix abnormalities in schizophrenia. Neuropharmacology (2011) 1.04
Peripheral biomarkers revisited: integrative profiling of peripheral samples for psychiatric research. Biol Psychiatry (2013) 0.98
Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations. Mol Psychiatry (2013) 0.98
Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia. Mol Psychiatry (2014) 0.98
Altered glutamate protein co-expression network topology linked to spine loss in the auditory cortex of schizophrenia. Biol Psychiatry (2014) 0.95
Postmortem brain: an underutilized substrate for studying severe mental illness. Neuropsychopharmacology (2013) 0.91
The application of selective reaction monitoring confirms dysregulation of glycolysis in a preclinical model of schizophrenia. BMC Res Notes (2012) 0.89
Altered serine/threonine kinase activity in schizophrenia. Brain Res (2014) 0.88
Biochemical fractionation and stable isotope dilution liquid chromatography-mass spectrometry for targeted and microdomain-specific protein quantification in human postmortem brain tissue. Mol Cell Proteomics (2012) 0.87
Mass spectrometry for the detection of potential psychiatric biomarkers. J Mol Psychiatry (2013) 0.87
Better understanding of mechanisms of schizophrenia and bipolar disorder: from human gene expression profiles to mouse models. Neurobiol Dis (2011) 0.86
Mutation of Semaphorin-6A disrupts limbic and cortical connectivity and models neurodevelopmental psychopathology. PLoS One (2011) 0.85
MK-801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: insights for schizophrenia. Front Cell Neurosci (2015) 0.83
Reduced protein synthesis in schizophrenia patient-derived olfactory cells. Transl Psychiatry (2015) 0.82
Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophrenia. Transl Psychiatry (2014) 0.82
Evidence of Mitochondrial Dysfunction within the Complex Genetic Etiology of Schizophrenia. Mol Neuropsychiatry (2015) 0.81
Locomotor hyperactivity in 14-3-3ζ KO mice is associated with dopamine transporter dysfunction. Transl Psychiatry (2013) 0.80
The proteome of schizophrenia. NPJ Schizophr (2015) 0.79
Neurodevelopmental disorders: mechanisms and boundary definitions from genomes, interactomes and proteomes. Transl Psychiatry (2013) 0.78
Chronic phencyclidine increases synapsin-1 and synaptic adaptation proteins in the medial prefrontal cortex. ISRN Psychiatry (2013) 0.77
Dissecting the Syndrome of Schizophrenia: Progress toward Clinically Useful Biomarkers. Schizophr Res Treatment (2011) 0.76
Searching human brain for mechanisms of psychiatric disorders. Implications for studies on schizophrenia. Schizophr Res (2014) 0.76
14-3-3ζ deficient mice in the BALB/c background display behavioural and anatomical defects associated with neurodevelopmental disorders. Sci Rep (2015) 0.76
Proteomic analysis of lymphoblastoid cells derived from monozygotic twins discordant for bipolar disorder: a preliminary study. PLoS One (2013) 0.76
Proteomic enrichment analysis of psychotic and affective disorders reveals common signatures in presynaptic glutamatergic signaling and energy metabolism. Int J Neuropsychopharmacol (2014) 0.76
Proteomic analysis of the postsynaptic density implicates synaptic function and energy pathways in bipolar disorder. Transl Psychiatry (2016) 0.75
Towards the Molecular Foundations of Glutamatergic-targeted Antidepressants. Curr Neuropharmacol (2017) 0.75
The DPYSL2 gene connects mTOR and schizophrenia. Transl Psychiatry (2016) 0.75
Proteomic and Microscopic Strategies towards the Analysis of the Cytoskeletal Networks in Major Neuropsychiatric Disorders. Int J Mol Sci (2016) 0.75
Identification of a plasma signature of psychotic disorder in children and adolescents from the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort. Transl Psychiatry (2017) 0.75
The Energy Metabolism Dysfunction in Psychiatric Disorders Postmortem Brains: Focus on Proteomic Evidence. Front Neurosci (2017) 0.75
The minimum information about a proteomics experiment (MIAPE). Nat Biotechnol (2007) 10.24
Current two-dimensional electrophoresis technology for proteomics. Proteomics (2004) 4.87
Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21
Guidelines for the next 10 years of proteomics. Proteomics (2006) 3.61
Anti-NMDA receptor encephalitis: an important differential diagnosis in psychosis. Br J Psychiatry (2011) 2.80
Characterization of the phospholemman knockout mouse heart: depressed left ventricular function with increased Na-K-ATPase activity. Am J Physiol Heart Circ Physiol (2007) 1.77
Hyperubiquitination of proteins in dilated cardiomyopathy. Proteomics (2003) 1.70
Omega-3 fatty acid deficiency disrupts endocytosis, neuritogenesis, and mitochondrial protein pathways in the mouse hippocampus. Front Genet (2013) 1.43
2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease. Proteomics (2009) 1.39
Detection and mapping of widespread intermolecular protein disulfide formation during cardiac oxidative stress using proteomics with diagonal electrophoresis. J Biol Chem (2004) 1.37
Ischemic preconditioning exaggerates cardiac damage in PKC-delta null mice. Am J Physiol Heart Circ Physiol (2004) 1.34
The utility of N,N-biotinyl glutathione disulfide in the study of protein S-glutathiolation. Mol Cell Proteomics (2005) 1.32
Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes. Proteomics (2006) 1.31
Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2. J Biol Chem (2002) 1.17
Androgens target prohibitin to regulate proliferation of prostate cancer cells. Oncogene (2004) 1.16
The role of bioinformatics in two-dimensional gel electrophoresis. Proteomics (2003) 1.12
Comparative analysis of OFFGel, strong cation exchange with pH gradient, and RP at high pH for first-dimensional separation of peptides from a membrane-enriched protein fraction. Proteomics (2009) 1.10
Loss of PKC-delta alters cardiac metabolism. Am J Physiol Heart Circ Physiol (2004) 1.10
Automated image alignment for 2D gel electrophoresis in a high-throughput proteomics pipeline. Bioinformatics (2008) 1.08
Membranous glomerulonephritis associated with follicular B-cell lymphoma and subepithelial deposition of IgG1-kappa paraprotein. Nephron Clin Pract (2003) 1.05
Proteomics of the heart: unraveling disease. Circ Res (2006) 1.05
F-actin capping (CapZ) and other contractile saphenous vein smooth muscle proteins are altered by hemodynamic stress: a proteonomic approach. Mol Cell Proteomics (2003) 1.04
alpha-Synuclein modulation of Ca2+ signaling in human neuroblastoma (SH-SY5Y) cells. J Neurochem (2009) 1.02
HUPO Brain Proteome Project: summary of the pilot phase and introduction of a comprehensive data reprocessing strategy. Proteomics (2006) 1.02
Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3. Arch Gen Psychiatry (2011) 0.99
Use of proteomics to discover novel markers of cardiac allograft rejection. J Proteome Res (2004) 0.99
Evidence for shared susceptibility to epilepsy and psychosis: a population-based family study. Biol Psychiatry (2012) 0.98
Proteomic analysis reveals protein changes within layer 2 of the insular cortex in schizophrenia. Proteomics (2008) 0.97
Alterations in subcellular localization of p38 MAPK potentiates endothelin-stimulated COX-2 expression in glomerular mesangial cells. J Biol Chem (2003) 0.96
iAnn: an event sharing platform for the life sciences. Bioinformatics (2013) 0.96
Proteomic profiling of chronic low-frequency stimulated fast muscle. Proteomics (2007) 0.95
Proteomic analysis of increased Parkin expression and its interactants provides evidence for a role in modulation of mitochondrial function. Proteomics (2009) 0.94
Is traumatic brain injury a risk factor for schizophrenia? A meta-analysis of case-controlled population-based studies. Schizophr Bull (2011) 0.93
Chronic adolescent exposure to Δ-9-tetrahydrocannabinol in COMT mutant mice: impact on psychosis-related and other phenotypes. Neuropsychopharmacology (2010) 0.93
The human heart proteome: Two-dimensional maps using narrow-range immobilised pH gradients. Electrophoresis (2006) 0.92
Time to articulate a vision for the future of plant proteomics - A global perspective: An initiative for establishing the International Plant Proteomics Organization (INPPO). Proteomics (2011) 0.91
Reversible cysteine-targeted oxidation of proteins during renal oxidative stress. J Am Soc Nephrol (2003) 0.91
Proteomic analysis of coronary sinus serum reveals leucine-rich α2-glycoprotein as a novel biomarker of ventricular dysfunction and heart failure. Circ Heart Fail (2011) 0.91
A quantitative investigation into the losses of proteins at different stages of a two-dimensional gel electrophoresis procedure. Proteomics (2005) 0.90
Proteomics of heart disease. Hum Mol Genet (2003) 0.89
Identification and functional characterization of cytoplasmic determinants of plasmid DNA nuclear import. J Biol Chem (2009) 0.89
Optimising ovine cerebrospinal fluid preparation for two-dimensional gel electrophoresis. Proteomics (2006) 0.87
Evidence of female-specific glial deficits in the hippocampus in a mouse model of prenatal stress. Eur Neuropsychopharmacol (2010) 0.87
Differential responses in three thalamic nuclei in moderately disabled, severely disabled and vegetative patients after blunt head injury. Brain (2004) 0.86
Image analysis tools and emerging algorithms for expression proteomics. Proteomics (2010) 0.86
Assessing the use of thermal treatment to preserve the intact proteomes of post-mortem heart and brain tissue. Proteomics (2009) 0.85
Differential protein expression at the stage of neural tube closure in the mouse embryo. J Biol Chem (2002) 0.85
Defining the protein repertoire of microneme secretory organelles in the apicomplexan parasite Eimeria tenella. Proteomics (2003) 0.85
Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways. Neuropsychopharmacology (2012) 0.84
Examination of 2-DE in the Human Proteome Organisation Brain Proteome Project pilot studies with the new RAIN gel matching technique. Proteomics (2006) 0.84
Lesions of the prelimbic prefrontal cortex prevent response conflict produced by action-outcome associations. Q J Exp Psychol (Hove) (2010) 0.84
Detection of enterovirus capsid protein VP1 in myocardium from cases of myocarditis or dilated cardiomyopathy by immunohistochemistry: further evidence of enterovirus persistence in myocytes. Med Microbiol Immunol (2003) 0.83
Proteomic analysis of factors released from p21-overexpressing tumour cells. Proteomics (2006) 0.83
Nonionic detergent phase extraction for the proteomic analysis of heart membrane proteins using label-free LC-MS. Proteomics (2008) 0.83
Urinary markers for prostate cancer. BJU Int (2006) 0.82
Temporal proteomic profile of memory consolidation in the rat hippocampal dentate gyrus. Proteomics (2011) 0.82
Protective effect of phosphorylated Hsp27 in coronary arteries through actin stabilization. J Mol Cell Cardiol (2010) 0.82
Measurement of specific radioactivity in proteins separated by two-dimensional gel electrophoresis. Electrophoresis (2006) 0.82
Optimization of the first dimension for separation by two-dimensional gel electrophoresis of basic proteins from human brain tissue. Proteomics (2004) 0.82
Peptide fractionation in proteomics approaches. Expert Rev Proteomics (2010) 0.82
The impact of tyrosine kinase 2 (Tyk2) on the proteome of murine macrophages and their response to lipopolysaccharide (LPS). Proteomics (2008) 0.81
The Rac/Cdc42 guanine nucleotide exchange factor beta1Pix enhances mastoparan-activated Gi-dependent pathway in mast cells. Biochem Biophys Res Commun (2004) 0.80
Partitioning the proteome: phase separation for targeted analysis of membrane proteins in human post-mortem brain. PLoS One (2012) 0.80
Crystallin distribution patterns in concentric layers from toad eye lenses. Proteomics (2009) 0.80
2-D DIGE as a quantitative tool for investigating the HUPO Brain Proteome Project mouse series. Proteomics (2006) 0.80
Preserving the yeast proteome from sample degradation. Proteomics (2009) 0.79
Analysis of the budding yeast pH 4-7 proteome in meiosis. Proteomics (2010) 0.79
Boosting the globalization of plant proteomics through INPPO: current developments and future prospects. Proteomics (2012) 0.79
ProteomeGRID: towards a high-throughput proteomics pipeline through opportunistic cluster image computing for two-dimensional gel electrophoresis. Proteomics (2004) 0.79
Endothelin signalling and regulation of protein kinases in glomerular mesangial cells. Clin Sci (Lond) (2002) 0.79
Murine retrovirus infection and the effect of chronic alcohol consumption: proteomic analysis of cardiac protein expression. Alcohol Alcohol (2003) 0.79
Priming the brain for psychosis: maternal inflammation during fetal development and the risk of later psychiatric disorder. Am J Psychiatry (2014) 0.79
A fluorescent codetection system for immunoblotting and proteomics through ECL-Plex and CyDye labeling. Methods Mol Biol (2009) 0.78
Cyclooxygenase-2 inhibits tumor necrosis factor alpha-mediated apoptosis in renal glomerular mesangial cells. J Biol Chem (2003) 0.78
Preparation of human heart for laser microdissection and proteomics. Proteomics (2004) 0.78
A proteomic study of cMyc improvement of CHO culture. BMC Biotechnol (2010) 0.78
2-D DIGE analysis of the budding yeast pH 6-11 proteome in meiosis. Proteomics (2010) 0.78
A 2-D gel reference map of the basic human heart proteome. Proteomics (2011) 0.78
Proteomic investigation of the hippocampus in prenatally stressed mice implicates changes in membrane trafficking, cytoskeletal, and metabolic function. Dev Neurosci (2014) 0.77
Investigation of hormone activity in butterfly imaginal wing discs by protein expression pattern changes. Electrophoresis (2007) 0.77
Two-dimensional reference map for the basic proteome of the human dorsolateral prefrontal cortex (dlPFC) of the prefrontal lobe region of the brain. Proteomics (2010) 0.77
Effect of phosphorylated hsp27 on proliferation of human endothelial and smooth muscle cells. Proteomics (2009) 0.77
CyDye immunoblotting for proteomics: co-detection of specific immunoreactive and total protein profiles. Proteomics (2006) 0.77
Role of proteomics in the investigation of pulmonary fibrosis. Expert Rev Proteomics (2007) 0.77
PROTEOMICS: ten years in the field. Proteomics (2010) 0.76
A systematic investigation into the recovery of radioactively labeled proteins from sodium dodecyl sulfate-polyacrylamide gels. Electrophoresis (2004) 0.76
Benefits of heat treatment to the protease packed neutrophil for proteome analysis: halting protein degradation. Proteomics (2011) 0.76
PROTEOMICS reviews 2013. Proteomics (2013) 0.76
Best practice in statistical reporting. Proteomics (2011) 0.76